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TO THE EDITOR
Several studies have used evidence
evaluating genetic alterations (Curtin
et al., 2005) and anatomic location
(Whiteman et al., 2003) to support
theories that melanoma is a heteroge-
neous disease with differing etiologies.
Using data from the large-scale, popula-
tion-based Surveillance, Epidemiology,
and End Results Program (SEER) of the
National Cancer Institute, we examined
whether age-specific incidence patterns
separated by sex and site would reveal
distinct melanoma subgroups.
Age, sex, and anatomic site were
abstracted for all microscopically con-
firmed, first invasive cutaneous mela-
nomas among non-Hispanic white
adults collected by the SEER 17 Registry
Program from 2000 to 2004. Incidence
rates, summarized across 5-year age
groups, were plotted by age at diagnosis
on a log-log scale, and age distribution
curves were created. Detailed materials
and methods are available in Supple-
mentary Materials and Methods.
After excluding 15 cases missing age
at diagnosis, 48,673 cases were available
for analysis (Table 1). Fifty-six percent of
patients were male, and the mean age at
diagnosis was 57.0 years. Forty-one
percent of all melanomas occurred
among those 40–59 years of age. How-
ever, the age-specific incidence rate
peaked among people aged 70–79 years,
who had an incidence rate 5.9 times
higher (95% confidence intervals,
5.6–6.2) than those aged 20–29 years.
The incidence rate ratio for females
compared to males was 0.7 (95% confi-
dence intervals, 0.7–0.7). Forty-three
percent of melanomas were located on
the extremities, 34% on the trunk, 12%
on the face/ears, 7% on the scalp/neck,
and 4% at other/unclassified sites.
The age-specific incidence rate curve
and the age distribution for all melano-
ma cases are shown in Figure 1. Rates
for all cases increased rapidly until age
55–59, then continued to rise at slower
rates before beginning to decline (Figure
1a). The age distribution plot displayed
a multimodal distribution, with distinct
Table 1. Frequency and incidence of invasive cutaneous melanoma in non-
Hispanic white adults collected by SEER-17 from 2000 to 20041 (n=48,673)
Characteristic n (%)2
Incidence rate per
100,000 (SE)
Incidence rate ratio
(95% CI)3
Age at diagnosis (years)
Mean+SD 57.0 (16.6) NA NA
Age groups (years)
20–29 2,391 (5) 9.1 (0.2) 1
30–39 5,188 (11) 16.2 (0.2) 1.8 (1.7–1.9)
40–49 9,376 (19) 25.5 (0.3) 2.8 (2.7–2.9)
50–59 10,585 (22) 35.5 (0.3) 3.9 (3.7–4.1)
60–69 8,541 (18) 46.5 (0.5) 5.1 (4.9–5.4)
70–79 7,769 (16) 53.3 (0.6) 5.9 (5.6–6.2)
80+ 4,823 (10) 49.6 (0.7) 5.5 (5.2–5.7)
Sex
Male 27,300 (56) 33.6 (0.2) 1
Female 21,373 (44) 24.7 (0.2) 0.7 (0.7–0.7)
Anatomic site
Extremities 21,008 (43) 12.5 (0.1) 1
Trunk 16,610 (34) 9.9 (0.1) 0.8 (0.8–0.8)
Face/ears 5,875 (12) 3.5 (o0.01) 0.3 (0.3–0.3)
Scalp/neck 3,300 (7) 2.0 (o0.01) 0.2 (0.2–0.2)
Other/unclassified 1,880 (4) 1.1 (o0.01) 0.1 (0.1–0.1)
CI, confidence interval; SD, standard deviation; SE, standard error; SEER, Surveillance, Epidemiology,
and End Results; NA, not applicable.
1Note: 15 cases were excluded for missing age at diagnosis.
2Percentages are rounded and may not sum to 100.
3Rate ratios compare rates for given characteristics to a referent characteristic with an assigned rate
ratio of 1.0.
Abbreviations: SEER, Surveillance, Epidemiology, and End Results
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early-onset and late-onset peak frequen-
cies of melanoma occurring at ages 54
and 74 years, respectively (Figure 1b).
Melanomas demonstrated different
incidence patterns by anatomic site.
Age-specific incidence rates among
those with trunk melanoma generally
increased until age 55–59 years, then
plateaued and subsequently declined
(Figure 1c). The flattening of rates for
trunk melanoma occurred earlier and
was more extreme for females than for
males. The age distribution of trunk
melanoma was predominantly uni-
modal, with early-onset peak frequencies
occurring at age 54 for males and 44 for
females (Figure 1d). In contrast, age-
specific incidence rates among those
with face/ear melanoma increased shar-
ply throughout older age (Figure 1e).
The age distribution for face/ear mela-
noma was unimodal with late-onset
peaks at age 77 for males and at age
78 for females (Figure 1f). Incidence
rates for melanomas of the extremi-
ties, scalp/neck, and other/unclassified
sites demonstrated various mixtures of
these two patterns and did not show
unimodal distributions (data not
shown). These distinct patterns for trunk
and face/ear melanomas were main-
tained when the analysis was limited to
those classified as superficial spreading
melanoma and nodular melanoma his-
tological subtypes (Figure 2).
The multimodal distribution of in-
vasive melanoma might be explained,
in part, by divergent patterns for ana-
tomic site. Broken down by site, trunk
melanomas displayed an early-onset
peak of melanoma incidence, while
face/ear melanomas demonstrated a
late-onset incidence peak. Comparable
divergent incidence rate patterns have
been noted for breast cancer, and the
bend in age-specific rates near meno-
pause has been termed Clemmesen’s
hook (Clemmesen, 1948; Anderson
et al., 2005). Clemmesen’s hook on
the age-specific incidence rate curve
has been shown to correspond to the
dip between the bimodal peaks of the
age distribution plot (Anderson et al.,
1950). Our data suggest the existence of
a Clemmesen’s hook for melanoma.
Bulliard (2000) analyzed age-and
surface area-adjusted incidence rates by
anatomic site for the non-Maori popula-
tion of New Zealand using data from
1968 to 1993 and found patterns similar
to ours. Elwood and Gallagher (1998)
examined site-specific incidence rates
per unit area of skin for 1,033 patients in
a Canadian melanoma registry and
noted that the density of melanoma on
the back exceeded that of the face before
age 50, but that melanoma density was
greatest on the face at later ages.
Additionally, Dennis (1999) used SEER
data collected during 1972–1994 to
examine age-specific incidence curves
by site adjusted for birth-cohort effects.
While adjusting for birth-cohort in-
creased incidence rates for all sites,
especially after age 50, the incidence
patterns for trunk and head resembled
those we found for trunk and face/ears.
Divergent age-specific incidence
patterns support hypotheses that mela-
nomas may emerge from more than one
causal pathway and complement recent
evidence identifying distinct melanoma
genotypes. Whiteman et al. (2003) have
proposed a ‘‘divergent pathway’’ model
in which people with inherently low
propensity for melanocyte proliferation
require chronic sun exposure to habi-
tually exposed sites, such as the face, to
develop melanoma, whereas people
with a high propensity for melanocyte
proliferation develop melanomas on
sites with unstable melanocytes, such
as the trunk, with less or intermittent
solar damage. Our data support this
model by displaying an early-onset
peak frequency for trunk melanomas
and a late-onset peak frequency for
face/ear melanomas. Additionally,
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Figure 1. Age-specific incidence rates and age distribution of melanoma. Age-specific incidence
rates per 100,000 population of invasive melanoma are shown for (a) all cases, (c) trunk melanomas,
and (e) face/ear melanomas. Age distributions are shown for (b) all cases, (d) trunk melanomas, and
(f) face/ear melanomas; the vertical axis represents smoothed estimates of the proportion of patients
who developed melanoma at the corresponding age at diagnosis on the horizontal axis. Rates and
distribution curves are depicted in solid lines for males and in dashed lines for females.
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BRAF mutations, found in 20–80% of
cutaneous melanomas (Lang and
MacKie, 2005), occur more frequently
in melanomas of patients o50 years of
age and are positively associated with
truncal location (Liu et al., 2007;
Thomas et al., 2007). BRAF mutations
are also significantly more likely to be
found in melanomas on skin without
evidence of chronic sun damage, as
reflected by the lack of severe histologi-
cal solar elastosis (Maldonado et al.,
2003; Curtin et al., 2005). Thus, our
epidemiologic incidence patterns match
what is already known about one geneti-
cally distinct type of melanoma.
Other evidence suggests that histo-
logical growth patterns may be useful in
identifying melanoma subtypes that
have distinctive biological behaviors
(Clark et al., 1969). It is well-known
that lentigo maligna melanoma, a sub-
type associated with cumulative sun
exposure, frequently occurs on the
head and neck in older adults (Cohen,
1995). Nevertheless, when our analysis
was limited to melanomas classified as
superficial spreading or nodular mela-
noma subtypes, the patterns by site
persisted.
Our analysis demonstrates the value
of using a large-scale, population-based
database for hypothesis-generating and
hypothesis-testing. Melanoma is a het-
erogeneous cancer and is likely to
represent tumors with multiple etio-
logies and perhaps different outcomes.
Further research on the genetic make-
up of distinct phenotypes will advance
our understanding of melanoma and
may improve our ability to prevent and
treat this disease.
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Figure 2. Age-specific incidence rates and age distributions by site and by histological subtype.
Age-specific incidence rates per 100,000 population of invasive superficial spreading (SSM) and
invasive nodular melanoma (NM) are shown for (a) trunk and (c) face/ear locations. Age distributions
of SSM and NM at (b) trunk and (d) face/ear locations are also shown. No cases of NM on the
face/ears were collected for the age group 20–24 years. Rates and distribution curves are depicted in
solid lines for SSM and in dashed lines for NM.
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